Anavex Life Sciences Corp (AVXL)

[Investor2014]

Thorough biochecking, with access to acquaintances who mingle with the upper echelons of biotech investors, shows that A2-73 won't work because 40 years of no results with S1R don't lie. You know much like the experience of removing amyloid plaque.

I think that is the essence of the thesis even by those who are apparently intrigued by the science, but want the CEO replaced to immediately see an enormous jump in SP.